Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target

导出原文传递

翻译打印收藏纠错

作者： Amirouchene-Angelozzi, Nabil ^[1] ; Nemati, Fariba ^[2] ; Gentien, David ^[3] ; Nicolas, Andre ^[4] ; Dumont, Amaury ^[5] ; Carita, Guillaume ^[6] ; Camonis, Jacques ^[7] ; Desjardins, Laurence ^[8] ; Cassoux, Nathalie ^[9] ; Piperno-Neumann, Sophie ; Mariani, Pascale ; Sastre, Xavier ; Decaudin, Didier ; Roman-Roman, Sergio

作者单位： Inst Curie, Dept Tumor Biol, F-75005 Paris, France ^[1] Inst Curie, Translat Res Dept, F-75005 Paris, France ^[2] Inst Curie, INSERM, F-75005 Paris, France ^[3] Inst Curie, Translat Res Dept, Lab Preclin Invest, F-75005 Paris, France ^[4] Inst Curie, Dept Med Oncol, F-75005 Paris, France ^[5] Inst Curie, Translat Res Dept, Genom Platform, F-75005 Paris, France ^[6] Inst Curie, Dept Ophthalmol Oncol, F-75005 Paris, France ^[7] Inst Curie, Dept Surg, F-75005 Paris, France ^[8] Inst Curie, Translat Res Dept, Biophen Lab, F-75005 Paris, France ^[9]

关键词 Uveal melanoma BAP1 Everolimus mTOR Cell lines Patients-derived tumor xenografts

发布时间 2015-03-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交